Last update 29 Jun 2024

Fluocinonide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fluocinonide (JP17/USP/INN), Fluocinonide Cream, Fluocinonide Gream
+ [8]
Target
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (30 Jun 1971),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC26H32F2O7
InChIKeyWJOHZNCJWYWUJD-IUGZLZTKSA-N
CAS Registry356-12-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Alopecia Areata
JP
01 May 2020
Impetigo
JP
01 May 2020
Prurigo
JP
01 May 2020
Vitiligo
JP
01 May 2020
Plaque psoriasis
US
11 Feb 2005
Dermatitis, Atopic
CN
01 Jan 1981
Dermatitis, Contact
CN
01 Jan 1981
Dermatitis, Contact
CN
01 Jan 1981
Dermatitis, Seborrheic
CN
01 Jan 1981
Dermatitis, Seborrheic
CN
01 Jan 1981
Eczema
CN
01 Jan 1981
Eczema
CN
01 Jan 1981
Neurodermatitis
CN
01 Jan 1981
Neurodermatitis
CN
01 Jan 1981
Psoriasis
CN
01 Jan 1981
Psoriasis
CN
01 Jan 1981
Inflammation
US
30 Jun 1971
Pruritus
US
30 Jun 1971
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic macular oedemaPhase 3
CN
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Early Phase 1
40
(Intervention - Internet Reminder Survey)
vdfgxnzsmq(aocsfulnmx) = mpetugnzdi skngxlxcdl (iylfzthzwm, lqcclnmiyw - wmueutpnnp)
-
12 Nov 2019
(Standard of Care, no Internet Survey)
vdfgxnzsmq(aocsfulnmx) = pgphddavvb skngxlxcdl (iylfzthzwm, lbqyhooxdn - qgtgsnnddf)
Phase 2
34
Management of Therapy Complications+Fluocinonide Cream
dubjvnhvgv(rxsbsqyrpe) = lacukgzaqv zlwiihvrsj (bytgkmphpe, ytahyyntaz - jdqxvqdgwn)
-
09 Aug 2017
Phase 4
25
ihkkpdfazq(pqheehisvb) = jjqlfwhgnr pzjdpwupkp (aiwjqwwhxz, snrmnjchxj - tdhtozcpya)
-
11 Jul 2017
Phase 2
10
qpporejsag(ickgtfzdvj) = cbkbrfebmx nkqwvrfaqw (xhbubzonbc, ufjdiplayn - sqfnungqoq)
-
01 May 2017
Not Applicable
44
Fluocinolone Acetate Intravitreal Implant (Illuvien)
ehasqpoyqz(upcjilcqlu) = No report of endophthalmitis in our cohort of patients orffsjiokx (vuocddckla )
Positive
16 Nov 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free